Clinical Trial

CART-BP Prospective Study for Hypertension Control

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 10, 2026 (before its estimated May 4, 2026 completion). Its status may not reflect the trial's current state.
Summary
This prospective, open-label, non-randomized study evaluates the effectiveness and safety of a CART BP pro(a brand name of cuffless ambulatory blood pressure monitoring device)-guided blood pressure management strategy in Korean patients with uncontrolled hypertension. Participants are allocated to either a CART BP pro-guided management group or a usual care group based on clinical decision and participant preference. The primary efficacy endpoint is 24-hour mean ambulatory systolic blood pressure at 24 weeks; safety outcomes including treatment-emergent adverse events (TEAEs) are also assessed.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-02.
Trial Details
NCT Number NCT07454148
Lead Sponsor Korea University Anam Hospital
Conditions Hypertension
Enrollment 288 participants
Start Date 2025-03-25
Primary Completion 2026-05-04 (estimated)
Study Completion 2026-05-04 (estimated)
Updated on ClinicalTrials.gov 2026-03-10